MTF

MTF Biologics Appoints Jeff Orlowski to Board of Directors

Retrieved on: 
Monday, March 6, 2023

MTF Biologics , a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients, and advancing the science of tissue transplantation, today announced that LifeShare of Oklahoma President and Chief Executive Officer Jeff Orlowski has joined its Board of Directors.

Key Points: 
  • MTF Biologics , a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients, and advancing the science of tissue transplantation, today announced that LifeShare of Oklahoma President and Chief Executive Officer Jeff Orlowski has joined its Board of Directors.
  • View the full release here: https://www.businesswire.com/news/home/20230306005625/en/
    Jeff Orlowski, LifeShare of Oklahoma President and Chief Executive Officer, has joined the board of directors of MTF Biologics, a global nonprofit organization that saves and heals lives by honoring donated gifts, serving patients, and advancing the science of tissue transplantation.
  • (Photo: Business Wire)
    “We are honored to welcome Jeff to our Board,” said Joe Yaccarino, president and CEO of MTF Biologics.
  • “I am honored to join the MTF Biologics Board and to represent the nation’s recovery programs in this capacity,” said Orlowski.

Mixel MIPI D-PHY IP Integrated into Teledyne e2v’s new Topaz CMOS Image Sensors

Retrieved on: 
Tuesday, February 28, 2023

Mixel ®, a leading provider of mixed-signal intellectual property (IP), and Teledyne e2v, a part of Teledyne Technologies [NYSE: TDY], announced today that Mixel’s MIPI® IP solution has been successfully integrated into the Topaz™ family of 2MP and 1.5MP resolution industrial CMOS sensors that are now in mass production.

Key Points: 
  • Mixel ®, a leading provider of mixed-signal intellectual property (IP), and Teledyne e2v, a part of Teledyne Technologies [NYSE: TDY], announced today that Mixel’s MIPI® IP solution has been successfully integrated into the Topaz™ family of 2MP and 1.5MP resolution industrial CMOS sensors that are now in mass production.
  • Topaz is Teledyne e2v’s second product family to leverage Mixel’s MIPI D-PHY IP.
  • The first was their Snappy CMOS image sensor family which integrated Mixel’s MIPI D-PHY IP and was first announced in 2019.
  • “The breadth of applications from barcode scanning to industrial robotics and to factory automation for Topaz image sensors truly speaks to the capabilities of Teledyne e2v’s product and the versatility of MIPI-based image sensors.”

Leidos Partnership Brings MHS GENESIS to East Coast

Retrieved on: 
Monday, February 6, 2023

RESTON, Va., Feb. 6, 2023 /PRNewswire/ -- The Leidos Partnership for Defense Health (LPDH) today announced it successfully delivered the MHS GENESIS electronic health record to an additional 12,000 clinicians and providers as part of its latest double wave deployment (Waves PORTSMOUTH/DRUM), spanning 11 parent Military Treatment Facilities (MTFs) in Connecticut, Delaware, Maine, New Jersey, New York, Rhode Island, New Hampshire and Virginia.

Key Points: 
  • "With each deployment, our team is continuing to expand both scalability and capacity," said Liz Porter, Leidos Health Group President.
  • The MHS GENESIS system is now operational at over 2,200 locations and reaches 6.1 million DOD beneficiaries — approximately 75% deployed to garrison DOD facilities.
  • "MHS GENESIS successfully leverages commercial best practices improving clinical outcomes with each deployment."
  • MHS GENESIS is being deployed across the continental United States and overseas through a total of 23 waves, with each wave targeting a specific region.

ARTEX MTF AG: ARTEX Establishes the World’s First Art Shares Exchange

Retrieved on: 
Wednesday, January 18, 2023

By becoming the world’s first art shares exchange, ARTEX will offer millions the opportunity to invest and trade in a new alternative asset class.

Key Points: 
  • By becoming the world’s first art shares exchange, ARTEX will offer millions the opportunity to invest and trade in a new alternative asset class.
  • The resulting art shares will be in the form of standardised transferable securities, like any equity shares listed on a stock exchange.
  • ARTEX has secured partnerships with well-established stock exchange infrastructure services providers to ensure a seamless trading experience and a robust trading platform.
  • UnaVista, an LSEG business, will support ARTEX in fulfilling its information exchange and reporting with the relevant supervisory bodies.

MTF Biologics Awards 2022 Extramural Research Grants

Retrieved on: 
Wednesday, January 11, 2023

MTF Biologics , a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research, has awarded more than $850,000 in funding to seven researchers across the nation through its 2022 Extramural Research Grants Program .

Key Points: 
  • MTF Biologics , a global nonprofit organization that saves and heals lives by advancing tissue and organ donation, transplantation, and research, has awarded more than $850,000 in funding to seven researchers across the nation through its 2022 Extramural Research Grants Program .
  • “We are so pleased that, even in the face of global economic uncertainty and ongoing challenges associated with the COVID-19 pandemic, MTF Biologics is able to continue giving back to the scientific and patient community through our Extramural Research Grants Program,” said Joe Yaccarino, president and CEO of MTF Biologics.
  • It is our hope that these studies will provide novel allograft-based options for a variety of clinical conditions.”
    2022 MTF Biologics Research Grants were awarded to the following:
    MTF BIOLOGICS EXTRAMURAL RESEARCH GRANT – ESTABLISHED INVESTIGATOR:
    MTF BIOLOGICS EXTRAMURAL RESEARCH GRANT– JUNIOR INVESTIGATOR:
    Mark Haber, M.D., Southern Orthopedics (Australia) “Allograft Augmentation of Irreparable Supraspinatus Tendon Tears: An Evaluation of Graft Healing Rate and Vascularity with Ultrasound And MRI, And Clinical Outcomes”)
    Meghan McCullough, M.D., Cedars Sinai Hospital “Use of allograft adipose matrix for small joint arthritis of the hand.
  • “We received many high quality grant proposals this year,” said Jeffrey Cartmell, Ph.D., director, Intellectual Property & Grants at MTF Biologics.

ARTEX MTF AG : ARTEX ESTABLISHES THE WORLD’S FIRST ART SHARES EXCHANGE

Retrieved on: 
Thursday, February 2, 2023

By becoming the world’s first art shares exchange, ARTEX will offer millions the opportunity to invest and trade in a new alternative asset class.

Key Points: 
  • By becoming the world’s first art shares exchange, ARTEX will offer millions the opportunity to invest and trade in a new alternative asset class.
  • The resulting art shares will be in the form of standardised transferable securities, like any equity shares listed on a stock exchange.
  • ARTEX has secured partnerships with well-established stock exchange infrastructure services providers to ensure a seamless trading experience and a robust trading platform.
  • UnaVista, an LSEG business, will support ARTEX in fulfilling its information exchange and reporting with the relevant supervisory bodies.

EQS-News: Go North Group AB (publ) has successfully placed SEK 550 million equivalent of senior secured floating rate bonds

Retrieved on: 
Thursday, February 2, 2023

Go North Group AB (publ) (“Go North” or the “Company”) has, following a bookbuilding process, successfully placed SEK 550 million equivalent of senior secured floating rate bonds with qualified investors in the Nordics, Europe, and the U.S. (the “New Bonds”).

Key Points: 
  • Go North Group AB (publ) (“Go North” or the “Company”) has, following a bookbuilding process, successfully placed SEK 550 million equivalent of senior secured floating rate bonds with qualified investors in the Nordics, Europe, and the U.S. (the “New Bonds”).
  • The New Bonds will be issued in two tranches of which SEK 350 million will be issued on the first issue date (the “SEK Tranche”) and equivalent to SEK 200 million is an underwritten subsequent bond issue (the “USD Tranche”).
  • The USD Tranche will be non-interest-bearing until any drawdown and New Bonds issued in the USD Tranche may be issued in either USD or SEK.
  • This information is information that Go North Group AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation.

'Surgutneftegas' PJSC: Information statement that, according to the issuer, exert a significant impact on the value or quotations of its securities

Retrieved on: 
Sunday, January 22, 2023

Dissemination of a Regulatory Announcement that contains inside information in accordance with the Market Abuse Regulation (MAR), transmitted by EQS Group.

Key Points: 
  • Dissemination of a Regulatory Announcement that contains inside information in accordance with the Market Abuse Regulation (MAR), transmitted by EQS Group.
  • The issuer is solely responsible for the content of this announcement.
  • Issues state registration numbers of the securities and their state registration date: ordinary shares: 1 01 00155-А dated 24 June 2003.
  • Date of the event (significant fact) about which the statement is made:
    [i] This Statement is a disclosure of the insider information.

Exberry Launches a Turnkey Solution to Ignite Carbon Markets and Fight Global Climate Change

Retrieved on: 
Thursday, December 15, 2022

Tel Aviv, Israel--(Newsfile Corp. - December 15, 2022) - Exberry , a leading provider of capital market trading technology that helps exchange pioneers launch, pivot, break ground, and scale, announces their latest product, Exberry for Carbon, a turnkey solution to ignite carbon markets and fight global climate change.

Key Points: 
  • Tel Aviv, Israel--(Newsfile Corp. - December 15, 2022) - Exberry , a leading provider of capital market trading technology that helps exchange pioneers launch, pivot, break ground, and scale, announces their latest product, Exberry for Carbon, a turnkey solution to ignite carbon markets and fight global climate change.
  • The expected surge calls for modern, flexible, and cost-effective trading technologies like Exberry for Carbon to accelerate the required market creation.
  • This situation prevents the creation of a global transparent carbon market and makes it almost impossible to trade carbon assets globally.
  • Carbon must be treated as a regulated asset to solve climate change on a global scale.

General Fusion exceeds core technology performance targets with plasma and compression prototypes

Retrieved on: 
Monday, December 12, 2022

Using large-scale prototypes, General Fusion has proven its core technology approach.

Key Points: 
  • Using large-scale prototypes, General Fusion has proven its core technology approach.
  • That’s why I chose Magnetized Target Fusion,” said Dr. Michel Laberge, Founder and Chief Science Officer, General Fusion.
  • Compression system prototype validates five millisecond compression time for fusion demonstration:
    General Fusion takes a pulsed approach to create fusion energy.
  • General Fusion’s primary compression prototype has completed over 1,000 shots, consistently achieving its compression performance targets.